Context Therapeutics (CNTX) PT Lowered to $4 at Maxim Group
Maxim Group analyst Jason McCarthy ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)